Literature DB >> 19360393

The co-evolution of our understanding of CD40 and inflammation.

D H Wagner1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19360393     DOI： 10.1007/s00125-009-1357-0

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  24 in total

Review 1.  The role of platelet CD154 in the modulation in adaptive immunity.

Authors:  Daniel L Sprague; Jennifer M Sowa; Bennett D Elzey; Timothy L Ratliff
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

2.  CD40 on NOD CD4 T cells contributes to their activation and pathogenicity.

Authors:  Rocky L Baker; David H Wagner; Kathryn Haskins
Journal:  J Autoimmun       Date:  2008-10-31       Impact factor: 7.094

3.  Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment.

Authors:  T Wekerle; J Kurtz; H Ito; J V Ronquillo; V Dong; G Zhao; J Shaffer; M H Sayegh; M Sykes
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

4.  Soluble CD154 in rheumatoid arthritis: elevated plasma levels in cases with vasculitis.

Authors:  N Tamura; S Kobayashi; K Kato; H Bando; K Haruta; M Oyanagi; M Kuriyama; T J Kipps; H Hashimoto
Journal:  J Rheumatol       Date:  2001-12       Impact factor: 4.666

5.  Cutting edge: CD40-induced expression of recombination activating gene (RAG) 1 and RAG2: a mechanism for the generation of autoaggressive T cells in the periphery.

Authors:  Gisela M Vaitaitis; Michelle Poulin; Richard J Sanderson; Kathryn Haskins; David H Wagner
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

6.  Comparison of inflammatory markers in patients with diabetes mellitus versus those without before and after coronary arterial stenting.

Authors:  Atul Aggarwal; David J Schneider; Burton E Sobel; Harold L Dauerman
Journal:  Am J Cardiol       Date:  2003-10-15       Impact factor: 2.778

7.  Clinical implications of elevated serum interleukin-6, soluble CD40 ligand, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in patients with acute ST-segment elevation myocardial infarction.

Authors:  Jing Tan; Qi Hua; Jing Gao; Zhen Xing Fan
Journal:  Clin Cardiol       Date:  2008-09       Impact factor: 2.882

8.  Enhanced levels of CD154 (CD40 ligand) on platelets in patients with chronic heart failure.

Authors:  Christian Stumpf; Christoph Lehner; Saeed Eskafi; Dorette Raaz; Atilla Yilmaz; Susanne Ropers; Alexander Schmeisser; Joseph Ludwig; Werner G Daniel; Christoph D Garlichs
Journal:  Eur J Heart Fail       Date:  2003-10       Impact factor: 15.534

9.  Role of the CD40-CD40 ligand interaction in CD4+ T cell contact-dependent activation of monocyte interleukin-1 synthesis.

Authors:  D H Wagner; R D Stout; J Suttles
Journal:  Eur J Immunol       Date:  1994-12       Impact factor: 5.532

10.  Activation of human dendritic cells through CD40 cross-linking.

Authors:  C Caux; C Massacrier; B Vanbervliet; B Dubois; C Van Kooten; I Durand; J Banchereau
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307
View more
  6 in total

1.  CD40 glycoforms and TNF-receptors 1 and 2 in the formation of CD40 receptor(s) in autoimmunity.

Authors:  Gisela M Vaitaitis; David H Wagner
Journal:  Mol Immunol       Date:  2010-06-19       Impact factor: 4.407

2.  CD40-mediated signalling influences trafficking, T-cell receptor expression, and T-cell pathogenesis, in the NOD model of type 1 diabetes.

Authors:  Gisela M Vaitaitis; Dan M Waid; Martin G Yussman; David H Wagner
Journal:  Immunology       Date:  2017-06-19       Impact factor: 7.397

Review 3.  Targeting Type 1 Diabetes: Selective Approaches for New Therapies.

Authors:  Daniel F Sheehy; Sean P Quinnell; Arturo J Vegas
Journal:  Biochemistry       Date:  2019-01-17       Impact factor: 3.162

4.  A CD40-targeted peptide controls and reverses type 1 diabetes in NOD mice.

Authors:  Gisela M Vaitaitis; Michael H Olmstead; Dan M Waid; Jessica R Carter; David H Wagner
Journal:  Diabetologia       Date:  2014-08-08       Impact factor: 10.122

5.  Amplified B lymphocyte CD40 signaling drives regulatory B10 cell expansion in mice.

Authors:  Jonathan C Poe; Susan H Smith; Karen M Haas; Koichi Yanaba; Takeshi Tsubata; Takashi Matsushita; Thomas F Tedder
Journal:  PLoS One       Date:  2011-07-25       Impact factor: 3.240

6.  Galectin-9 controls CD40 signaling through a Tim-3 independent mechanism and redirects the cytokine profile of pathogenic T cells in autoimmunity.

Authors:  Gisela M Vaitaitis; David H Wagner
Journal:  PLoS One       Date:  2012-06-07       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.